Serotonin 2C receptor (5-HT2CR) mRNA editing-induced down-regulation of 5-HT2CR function in Xenopus oocytes: The significance of site C editing

Journal of Pharmacological Sciences

Volumn 113, Issue 4, 2010, Pages 362-367

  Tohda, Michihisa ^a   Hang, Pham T N ^a   Kobayashi, Naofumi ^a   Matsumoto, Kinzo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Phospholipase C; RNA editing; Serotonin 2C receptor subtype; Xenopus oocyte

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; PHOSPHOLIPASE C; SEROTONIN; SEROTONIN 2C RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; NONHUMAN; OOCYTE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RNA EDITING; VOLTAGE CLAMP; XENOPUS;

EID: 77956204828     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10094FP     Document Type: Article

References (25)

1. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, et al. Regulation of serotonin-2C receptor Gprotein coupling by RNA editing. Nature. 1997;387:303-308.
2. Higuchi M, Single FN, Köhler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell Mol Neurobiol. 1993;75:1361-1370.
3. Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP, et al. Messenger RNA editing of the human serotonin 5-HT 2C receptor. Neuropsychopharmacology. 1999;21:82S-90S.
4. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem. 1999;274:9472-9478.
5. Herrick-Davis K, Grinde E, CM N. Serotonin 5-HT 2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem. 1999;73:1711-1717.
6. Quirk K, Lawrence A, Jones J, Misra A, Harvey V, Lamb H, et al. Characterization of agonist binding on human 5-HT 2C receptor isoforms. Eur J Pharmacol. 2001;419:107-112.
7. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin 2C receptors. J Neurochem. 2000;74:1290-1300.
8. McGrew L, Price RD, Hackler E, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT 2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol. 2004;65:252-256.
9. Berg KA, Dunlop J, Sanchez T, Silva M, Clarke WP. A conservative, single-amino acid substitution in the second cytoplasminc domain of the human serotonin 2C receptor alters both ligand-dependent and-independent receptor signaling. J Pharm Exp Ther. 2008;324:1084-1092.
10. Tohda M, Hang PN, Matsumoto K. Developmental changes in serotonin 2C receptor mRNA editing in the rat cerebral cortex and primary cultured cortical neurons. Biol Pharm Bull. 2009;32:289-292.
11. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron. 2002;34:349-356.
12. Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett. 2003;346:169-172.
13. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, et al. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology. 2001;24:478-491.
14. Sodhi M, Burnet P, AJM, Kerwin R, Harrison P. RNA editing of the 5-HT2C receptor is reduced in schizophrenia. Mol Psychiatry. 2001;6:373-379.
15. Tohda M, Nomura M, Nomura Y. Molecular pathopharmacology of 5-HT 2C receptors and the RNA editing in the brain. J Pharmacol Sci. 2006;100:427-432.
16. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci. 2002;22:10529-10532.
17. Grayson DR, Ikonomovic S. In vitro neurochemical techniques (Neuromethods). Clifton: Humana;1998. p. 127-151.
18. Dong E, Matsumoto K, Uzunova V, Sugaya I, Takahata H, Nomura H, et al. Brain 5 α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci U S A. 2001;98:2849-2854.
19. Tohda M, Takasu T, Nomura Y. Effects of antidepressants on serotonin-evoked current in Xenopus oocytes injected with rat brain mRNA. Eur J Pharmacol. 1989;166:57-63.
20. Matsumoto K, Morhishige R, Tohda M, Murakami Y, Takayama H, Aimi N, et al. Suppressive effects of isorhynchophylline on 5-HT 2A receptor function in the brain: behavioral and electrophysiological study. Eur J Pharmacol. 2005;517:191-199.
21. Meyerhof W, Richter D. Identification of G protein-coupled receptors by RNase H-mediated hybrid depletion using Xenopus laevis oocytes as expression system. FEBS Lett. 1990;266:192-194.
22. Moriarty TM, Sealfon SC, Carty DJ, Roberts JL, Iyengar R, Landau EM. Coupling of exogenous receptors to phospholipase C in Xenopus oocytes through pertussis toxin-sensitive and-insensitive pathways. Cross-talk through heterotrimeric G-proteins. J Biol Chem. 1989;264:13524-13530.
23. Maas S, Kawahara Y, Tamburro KM, Nishikura K. A-to-I RNA editing and human disease. RNA Biol. 2006;3:1-9.
24. Tohda M, Sukma M, Nomura Y, Watanabe H. The mRNA expression of serotonin 2C subtype receptors uncoupled with inositol hydrolysis in NG108-15 cells. Jpn J Pharmacol. 2002;90:138-144.
25. Cavaillé J, Buiting K, Kiefmann M, Lalande M, Brannan CI, Horsthemke B, et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci U S A. 2000;97:14311-14316.